Gregory L. Weaver - Jun 1, 2023 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
EVP & CFO, Director
Signature
/s/ Gregory L. Weaver
Stock symbol
ATOS
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/5/2023, 09:00 AM
Previous filing
May 5, 2023
Next filing
Jun 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +2.6M $0.00 2.6M Jun 1, 2023 Common Stock 2.6M $0.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest with respect to 25% on the one year anniversary of June 1, 2023, and the remainder shall vest in equal quarterly installments over the following three years, subject to the reporting person's continued service through each applicable vesting date.